Baird Medical Investment Holdings Limited (BDMD)
| Market Cap | 53.91M -75.5% |
| Revenue (ttm) | 22.54M -39.2% |
| Net Income | -27.28M |
| EPS | -0.98 |
| Shares Out | 30.81M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 266,711 |
| Open | 1.890 |
| Previous Close | 1.860 |
| Day's Range | 1.720 - 1.930 |
| 52-Week Range | 0.757 - 7.262 |
| Beta | -1.19 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Apr 29, 2026 |
About BDMD
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People’s Republic of China. The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps, as well as soft tissue ablation. It sells its products through third-party distri... [Read more]
Financial Performance
Financial StatementsNews
Baird Medical Reports Full Year 2025 Financial Results and Provides Corporate Update
Full year 2025 revenue of $22.5 million, impacted by policy-driven slowdown in Mainland China Advancing global expansion with appointment of seasoned commercial leader, Mark Saxton, as CEO of Baird Me...
Baird Medical announces execution of two training shops in Indonesia
Baird Medical (BDMD) Investment announced the successful execution of two clinical training workshops in Indonesia. This initiative supports the Company’s strategic expansion in Southeast Asia by prov...
Baird Medical Advances Clinical Education with Expert-Led Workshops in Indonesia
NEW YORK, March 16, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) techno...
Baird Medical Expands Global Reach with Regulatory Clearance in Argentina
NEW YORK, March 12, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) techno...
Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology at NASIT 2026
NEW YORK, March 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Accelerates Global Registration of AI-Driven Surgical Software
NEW YORK, March 4, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announ...
Baird Medical Accelerates U.S. Expansion at NASOIE 2026
NEW YORK, March 2, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology
NEW YORK, Feb. 25, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical to Showcase Minimally Invasive Thyroid Solutions at Upcoming US Clinical Conferences
NEW YORK, Feb. 19, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Drives U.S. Market Penetration with Commercial Launch at Bakersfield Memorial Hospital
NEW YORK, Feb. 11, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Accelerates Global Commercial Roadmap with Strategic Clinical Education Initiatives in the U.S. and Japan
NEW YORK, Feb. 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technolo...
Baird Medical Successfully Concludes Gynecology Microwave Ablation Masterclass
NEW YORK, Jan. 28, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) techno...
Baird Medical enters strategic partnership with Stonewood Key Capital
Baird Medical (BDMD) announced a strategic partnership with Stonewood Key Capital, a wholly-owned comprehensive investment management enterprise from New Zealand. This collaboration positions the Hain...
Baird Medical Accelerates Global Commercial Roadmap through Strategic Partnership with Stonewood Key Capital
NEW YORK, Jan. 26, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Highlights Strategic Engagement at 2026 J.P. Morgan Healthcare Conference
NEW YORK, Jan. 20, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical secures regulatory approvals in Pakistan, Vietnam
Baird Medical (BDMD) announced it has reached key regulatory milestones with official product registrations from both the Medical Device Board of Pakistan and the Ministry of Health of Vietnam. In
Baird Medical Secures Regulatory Approvals in Pakistan and Vietnam
NEW YORK, Jan. 7, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in Microwave Ablation (MWA) technology, today announced...
Baird Medical to establish dedicated manufacturing base in the U.S.
Baird Medical (BDMD) Investment Holdings announced the establishment of a dedicated manufacturing base in the U.S. The decision to anchor production in North America is driven by the Company’s rapid
Baird Medical Establishes U.S. Manufacturing Base to Accelerate Global Expansion and Future R&D
NEW YORK , Dec. 17, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in Microwave Ablation (MWA) technology, today announc...
Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion
NEW YORK , Dec. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technol...
Baird Medical Enters Egyptian Market with First Successful Bone Tumor Ablation
NEW YORK , Nov. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its official l...
Baird Medical's MWA System Achieves Successful Medicare Reimbursement at Prominent New York Practice
NEW YORK , Oct. 27, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced the clinical ...
Baird Medical Announces First Successful Liver Tumor Ablation in Bangladesh
NEW YORK , Oct. 23, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successfu...
Baird Medical Fosters Advanced Physician Training at International Thyroid Microwave Ablation Workshop in Malaysia
NEW YORK , Oct. 21, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its successfu...
Baird Medical Champions Global Collaboration in Microwave Ablation at International Thyroid Workshop
NEW YORK , Oct. 20, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participa...